Company Description

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally.

The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform.

The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022.

Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.

Intelligent Bio Solutions Inc.

Country	United States
Founded	2016
Industry	Medical Devices
Sector	Healthcare
Employees	55
CEO	Harry Simeonidis

Contact Details

Address: 135 West, 41st Street, 5th Floor New York, New York 10036 United States
Phone	646 828 8258
Website	ibs.inc

Stock Details

Ticker Symbol	INBS
Exchange	NASDAQ
Fiscal Year	July - June
Reporting Currency	USD
CIK Code	1725430
CUSIP Number	36151G709
ISIN Number	US36151G7097
Employer ID	82-1512711
SIC Code	3841

Key Executives

Name	Position
Harry Simeonidis	President and Chief Executive Officer
Spiro Kevin Sakiris B.Bus, C.A., Dip Law	Chief Financial Officer
Callistus Sequeira	Vice President of Global Quality and Operations
Doug Heath	Vice President of Global Sales
Anna Turkington	Vice President of Marketing

Latest SEC Filings

Date	Type	Title
Jan 28, 2026	8-K	Current Report
Jan 21, 2026	EFFECT	Notice of Effectiveness
Jan 21, 2026	424B3	Prospectus
Jan 13, 2026	D	Notice of Exempt Offering of Securities
Jan 9, 2026	S-3	Registration statement under Securities Act of 1933
Jan 8, 2026	8-K	Current Report
Jan 2, 2026	8-K	Current Report
Dec 31, 2025	8-K	Current Report
Dec 16, 2025	8-K	Current Report
Dec 12, 2025	8-K	Current Report

View All SEC Filings